Memorias do Instituto Oswaldo Cruz
Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 - 2022)
Par Herazo R, Caicedo Díaz RA, Vera Soto MJ et 4 autres.
Contenu en anglais
Résumé
Background
In 2017, an estimated 1.2% of the population at risk for Chagas disease (CD) in Colombia was screened, and only 0.4% were treated. The recent implementation of CD-related Care roadmap has improved access to diagnosis and treatment. However, a therapeutic gap (TG) persists.
Objectives
In this work, we aim to analyse the TG for Trypanosoma cruzi/CD infection in Colombia over the last years.